Patents by Inventor Mark Ware

Mark Ware has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS COMPRISING CANNABIDIOL, TETRAHYDROCANNABINOL, TERPENES, AND FLAVONOIDS AND USE THEREOF IN THE TREATMENT OF INSOMNIA
    Publication number: 20200281890
    Abstract: Compositions comprising two or more cannabinoids, a terpene, and a flavonoid suitable for use in treating insomnia are disclosed. In preferred embodiments, the cannabinoids are cannabidiol and tetrahydrocannabinol, while the terpenes and flavonoids are selected from compounds that naturally occur in Cannabis extracts. Methods of treating insomnia by administering such compositions by a variety of routes are also disclosed.
    Type: Application
    Filed: September 25, 2018
    Publication date: September 10, 2020
    Inventors: Laura MACNAIR, Rami BATAL, Mark Andrew HETHERINGTON, Mark WARE, Chris SCHNARR, Steve KRAWCYZK
  • Use of Toll-Like Receptor 4 Antagonists for the Treatment or Prevention of Osteoarthritic Conditions
    Publication number: 20090136509
    Abstract: Methods for treating or preventing osteoarthric conditions using Toll-Like Receptor 4 (TLR4) antagonists are disclosed.
    Type: Application
    Filed: October 31, 2008
    Publication date: May 28, 2009
    Inventors: Simon Blake, Vedrana Stojanovic-Susulic, Mark Ware, Linda Wu
  • Enhanced variants of erythropoietin and methods of use
    Publication number: 20040157293
    Abstract: The invention provides a human erythropoietin polypeptide variant containing a human erythropoietin amino acid sequence having an amino acid difference in two or more different Epo-modification regions and an enhanced erythropoietin activity, or a functional fragment thereof. Also provided is a human erythropoietin polypeptide variant containing a human erythropoietin amino acid sequence having an amino acid difference in two or more different Epo-modification regions and a moderated erythropoietin activity, or a functional fragment thereof.
    Type: Application
    Filed: November 7, 2003
    Publication date: August 12, 2004
    Inventors: Glen A. Evans, Sally Jewell, Mark Ware
  • Enhanced variants of erythropoietin and methods of use
    Publication number: 20040091961
    Abstract: The invention provides a human erythropoietin polypeptide variant containing a human erythropoietin amino acid sequence having an amino acid difference in two or more different Epo-modification regions and an enhanced erythropoietin activity, or a functional fragment thereof. Also provided is a human erythropoietin polypeptide variant containing a human erythropoietin amino acid sequence having an amino acid difference in two or more different Epo-modification regions and a moderated erythropoietin activity, or a functional fragment thereof.
    Type: Application
    Filed: November 8, 2002
    Publication date: May 13, 2004
    Inventors: Glen A. Evans, Sally Jewell, Mark Ware